These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29770794)

  • 1. Ursodeoxycholic acid protects interstitial Cajal-like cells in the gallbladder from undergoing apoptosis by inhibiting TNF-α expression.
    Wan JF; Chu SF; Zhou X; Li YT; He WB; Tan F; Luo P; Ai QD; Wang Q; Chen NH
    Acta Pharmacol Sin; 2018 Sep; 39(9):1493-1500. PubMed ID: 29770794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of interstitial Cajal-like cells in the formation of cholesterol stones in guinea pig gallbladder.
    Fan Y; Wu S; Fu B; Weng C; Wang X
    Hepatol Int; 2015 Oct; 9(4):612-20. PubMed ID: 25788205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibiting effects of recipe for dispersing stagnated liver qi to promote bile flow on cholesterol gallstone formation in guinea pigs].
    Fang BJ; Zhu PT; Zhang JZ; Pei XJ; Yang YX; Liang XQ
    Zhong Xi Yi Jie He Xue Bao; 2006 Jan; 4(1):56-9. PubMed ID: 16409972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long term hydrophilic bile acid therapy on in vitro contraction of gallbladder muscle strips in patients with cholesterol gallstones.
    Mas MR; Comert B; Mas N; Yamanel L; Ozotuk H; Tasci I; Jazrawi RP
    World J Gastroenterol; 2007 Aug; 13(32):4336-9. PubMed ID: 17708607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-3 polyunsaturated fatty acid attenuates cholesterol gallstones by suppressing mucin production with a high cholesterol diet in mice.
    Kim JK; Cho SM; Kang SH; Kim E; Yi H; Yun ES; Lee DG; Cho HJ; Paik YH; Choi YK; Haam SJ; Shin HC; Lee DK
    J Gastroenterol Hepatol; 2012 Nov; 27(11):1745-51. PubMed ID: 22849613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ursodeoxycholic acid decreases viscosity and sedimentable fractions of gallbladder bile in patients with cholesterol gallstones.
    Fischer S; Müller I; Zündt BZ; Jüngst C; Meyer G; Jüngst D
    Eur J Gastroenterol Hepatol; 2004 Mar; 16(3):305-11. PubMed ID: 15195895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ursodeoxycholic acid therapy on in vitro gallbladder contractility in patients with cholesterol gallstones.
    van de Heijning BJ; van de Meeberg PC; Portincasa P; Doornewaard H; Hoebers FJ; van Erpecum KJ; Vanberge-Henegouwen GP
    Dig Dis Sci; 1999 Jan; 44(1):190-6. PubMed ID: 9952243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ursodeoxycholic acid on inflammatory infiltrate in gallbladder muscle of cholesterol gallstone patients.
    Carotti S; Guarino MP; Cicala M; Perrone G; Alloni R; Segreto F; Rabitti C; Morini S
    Neurogastroenterol Motil; 2010 Aug; 22(8):866-73, e232. PubMed ID: 20426797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Ursodeoxycholic Acid in the Prevention of Cholelithiasis After Sleeve Gastrectomy.
    Coupaye M; Calabrese D; Sami O; Siauve N; Ledoux S
    Obes Surg; 2019 Aug; 29(8):2464-2469. PubMed ID: 30945151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophils injure gallbladder interstitial Cajal-like cells in a guinea pig model of acute cholecystitis.
    Lin MJ; Chen L; Huang ZP; Qiu H; Yu BP
    J Cell Physiol; 2019 Apr; 234(4):4291-4301. PubMed ID: 30146704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ursodeoxycholic acid protects concanavalin A-induced mouse liver injury through inhibition of intrahepatic tumor necrosis factor-alpha and macrophage inflammatory protein-2 production.
    Ishizaki K; Iwaki T; Kinoshita S; Koyama M; Fukunari A; Tanaka H; Tsurufuji M; Sakata K; Maeda Y; Imada T; Chiba K
    Eur J Pharmacol; 2008 Jan; 578(1):57-64. PubMed ID: 17888421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gallbladder interstitial Cajal-like cells and gallbladder contractility in patients with cholelithiasis: a prospective study.
    Ding R; Wei J; Xu J
    Folia Histochem Cytobiol; 2019; 57(2):94-100. PubMed ID: 31237344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ursodeoxycholic acid exerts no beneficial effect in patients with symptomatic gallstones awaiting cholecystectomy.
    Venneman NG; Besselink MG; Keulemans YC; Vanberge-Henegouwen GP; Boermeester MA; Broeders IA; Go PM; van Erpecum KJ
    Hepatology; 2006 Jun; 43(6):1276-83. PubMed ID: 16729326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic apolipoprotein A-I gene expression in patients with cholesterol gallstones treated with ursodeoxycholic acid.
    Méndez-Sánchez N; Panduro A; Murguía D; Rincón AR; Uribe M
    Ann Hepatol; 2002; 1(2):85-9. PubMed ID: 15115973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway.
    Hu J; Hong W; Yao KN; Zhu XH; Chen ZY; Ye L
    World J Gastroenterol; 2019 Mar; 25(12):1492-1501. PubMed ID: 30948912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of gallstones by ursodeoxycholic acid after cardiac surgery.
    Ai T; Azemoto R; Saisho H
    J Gastroenterol; 2003; 38(11):1071-6. PubMed ID: 14673725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and functional study of cholecystokinin-A receptors on the interstitial Cajal-like cells of the guinea pig common bile duct.
    Xu D; Ma SL; Huang ML; Zhang H
    World J Gastroenterol; 2023 Oct; 29(38):5374-5382. PubMed ID: 37900582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Neutrophils on Gallbladder Interstitial Cajal-Like Cells in Guinea Pig Model of Acute Cholecystitis.
    Huang ZP; Qiu H; Yang Y; Yu BP
    Cell Physiol Biochem; 2016; 39(5):2033-2043. PubMed ID: 27825164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term ursodeoxycholic acid treatment improves gallbladder bile turnover in gallstone patients: a randomized trial.
    Guarino MP; Carotti S; Sarzano M; Alloni R; Vanni M; Grosso M; Sironi G; Maffettone PL; Cicala M
    Neurogastroenterol Motil; 2005 Oct; 17(5):680-6. PubMed ID: 16185306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythromycin, a motilin agonist, increases postprandial gallbladder emptying during therapy with ursodeoxycholic acid.
    Neubrand M; Sauerbruch T
    Z Gastroenterol; 1998 Apr; 36(4):267-71. PubMed ID: 9612923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.